[Coagulative influence of 5-oxo-6-amino-7-ketimino-6-phenyldibenzo(a.c)cycloheptan].
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D003018:Clot Retraction; D003508:Cycloheptanes / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D005260:Female; D007097:Imines / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007659:Ketones / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D011517:Prothrombin Time; D051381:Rats; D013329:Structure-Activity Relationship; D014812:Vitamin K / Q000494:pharmacology
D000925:Anticoagulants; D003508:Cycloheptanes; D007097:Imines; D007659:Ketones; D014812:Vitamin K
Uber die koagulierende wirkung von 5-Oxo-6-amino-7-ketimino-6-phenyldibenzo(a.c)cycloheptan.